Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative intravenous lidocaine for postoperative fatigue after radical colorectal cancer resection
ChiCTR2400094368Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Shanxi Medical University
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of lidocaine in colorectal cancer (CRC) (2 arms), sponsored by First Affiliated Hospital of Shanxi Medical University. Primary endpoint: Postoperative fatigue syndrome positive rate. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
lidocaine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR2400094368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400094368.